USE OF LEUKEMIA INHIBITORY FACTOR AND ENDOTHELIN ANTAGONISTS

摘要

A leukemia inhibitory factor antagonist, alone or in combination with anendothelin antagonist, may be used for treatment of heartfailure. The antagonist(s) are administered in a chronic fashion, intherapeutically effective amounts, to achieve this purpose.